Abstract 064 Randomised responders in remission by concomitant therapy, n/N (%)
| Week | Therapy | PBO | ADA, EOW | ADA, W |
|---|---|---|---|---|
| Statistical significance: *p<0.001; **p<0.05; ***p<0.01, all v PBO. | ||||
| 26 | IMM | 14/83 (17) | 32/77 (42) | 32/79 (41) |
| No IMM | 15/87 (17) | 36/95 (38) | 41/78 (53) | |
| Prior anti-TNF | 13/81 (16) | 28/86 (33)** | 30/71 (42)* | |
| No prior anti-TNF | 16/89 (18) | 40/86 (47)* | 43/86 (50)* | |
| 56 | IMM | 10/83 (12) | 30/77 (39) | 28/79 (35) |
| No IMM | 10/87 (12) | 32/95 (34) | 37/78 (47) | |
| Prior anti-TNF | 8/81 (10) | 26/86 (30)*** | 24/71 (34)* | |
| No prior anti-TNF | 12/89 (14) | 36/86 (42)* | 41/86 (48)* | |